Spero Therapeutics Inc (SPRO)
1.25
-0.06
(-4.58%)
USD |
NASDAQ |
Nov 14, 16:00
1.28
+0.03
(+2.40%)
After-Hours: 07:21
Spero Therapeutics Free Cash Flow: -14.38M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.38M |
| March 31, 2024 | -14.20M |
| December 31, 2023 | -33.00M |
| September 30, 2023 | 28.98M |
| June 30, 2023 | 12.11M |
| March 31, 2023 | 7.639M |
| December 31, 2022 | -7.731M |
| September 30, 2022 | -79.56M |
| June 30, 2022 | -83.56M |
| March 31, 2022 | -77.09M |
| December 31, 2021 | -64.35M |
| September 30, 2021 | -53.38M |
| June 30, 2021 | -69.69M |
| March 31, 2021 | -78.02M |
| Date | Value |
|---|---|
| December 31, 2020 | -86.03M |
| September 30, 2020 | -87.13M |
| June 30, 2020 | -75.49M |
| March 31, 2020 | -62.74M |
| December 31, 2019 | -50.33M |
| September 30, 2019 | -48.76M |
| June 30, 2019 | -44.62M |
| March 31, 2019 | -38.59M |
| December 31, 2018 | -39.62M |
| September 30, 2018 | -38.86M |
| June 30, 2018 | -43.86M |
| March 31, 2018 | -44.09M |
| December 31, 2017 | -39.11M |
Free Cash Flow Range, Past 5 Years
-87.13M
Minimum
Sep 2020
28.98M
Maximum
Sep 2023
-46.73M
Average
-62.74M
Median
Mar 2020
Free Cash Flow Benchmarks
| Arbutus Biopharma Corp | -71.92M |
| Equillium Inc | -15.77M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -31.50M |
| iBio Inc | -18.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.74M |
| Free Cash Flow Per Share (Quarterly) | -0.3474 |
| Free Cash Flow to Equity (Quarterly) | -18.74M |
| Free Cash Flow Yield | -21.48% |